Hualan Biological Engineering
002007.SZ
#2946
Rank
ยฃ3.47 B
Marketcap
ยฃ1.90
Share price
1.28%
Change (1 day)
-26.59%
Change (1 year)
Hualan Biological Engineering Inc. is a Chinese pharmaceutical company that produces plasma products and vaccines.

Revenue for Hualan Biological Engineering (002007.SZ)

Revenue in 2024 (TTM): ยฃ0.53 Billion

According to Hualan Biological Engineering's latest financial reports the company's current revenue (TTM ) is ยฃ0.54 Billion. In 2023 the company made a revenue of ยฃ0.59 Billion an increase over the revenue in the year 2022 that were of ยฃ0.54 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Hualan Biological Engineering from 2004 to 2024

Annual revenue

Year Revenue Change
2024 (TTM) ยฃ0.53 B-9.4%
2023 ยฃ0.59 B7.53%
2022 ยฃ0.54 B7.94%
2021 ยฃ0.50 B-6.53%
2020 ยฃ0.54 B34.16%
2019 ยฃ0.40 B7.49%
2018 ยฃ0.37 B44.09%
2017 ยฃ0.26 B11.7%
2016 ยฃ0.23 B49.11%
2015 ยฃ0.15 B21.71%
2014 ยฃ0.12 B16.88%
2013 ยฃ0.11 B15.5%
2012 ยฃ95.74 M-0.58%
2011 ยฃ96.3 M-20.81%
2010 ยฃ0.12 B10.07%
2009 ยฃ0.11 B133.69%
2008 ยฃ47.27 M101.24%
2007 ยฃ23.49 M3.16%
2006 ยฃ22.77 M-11.25%
2005 ยฃ25.66 M26.95%
2004 ยฃ20.21 M